{"date":"2025-07-10","count":23,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6586-2025-07-10-2322-16p7v3u","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2025-07-10","time":"23:22:17","subject":"更新本公司研發之醣抗原抗體抗癌新藥(簡稱:CHO-A04)向美國食品藥物管理局(FDA)提出人體臨床試驗審查申請(IND)","clause":"第44款","fact_date":"2025-07-10","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2025-07-10 23:22，「更新本公司研發之醣抗原抗體抗癌新藥(簡稱:CHO-A04)向美國食品藥物管理局(FDA)提出人體臨床試驗審查申請(IND」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2025-07-10-2153-1l16qil","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2025-07-10","time":"21:53:19","subject":"本公司研發之醣抗原抗體抗癌新藥(簡稱:CHO-A04)向美國食品藥物管理局(FDA)提出人體臨床試驗審查申請(IND)","clause":"第44款","fact_date":"2025-07-11","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2025-07-10 21:53，「本公司研發之醣抗原抗體抗癌新藥(簡稱:CHO-A04)向美國食品藥物管理局(FDA)提出人體臨床試驗審查申請(IND)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2025-07-10-2043-10j97ib","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2025-07-10","time":"20:43:42","subject":"更正本公司114年6月份背書保證申報限額資訊","clause":"第53款","fact_date":"2025-07-10","cite_as":"公開資訊觀測站重大訊息：天良（4127），2025-07-10 20:43，「更正本公司114年6月份背書保證申報限額資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2025-07-10-1816-c6ez1w","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2025-07-10","time":"18:16:21","subject":"更正本公司114年6月份資金貸與他人申報限額資訊","clause":"第53款","fact_date":"2025-07-10","cite_as":"公開資訊觀測站重大訊息：天良（4127），2025-07-10 18:16，「更正本公司114年6月份資金貸與他人申報限額資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2025-07-10-1815-1g9moz1","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2025-07-10","time":"18:15:07","subject":"公告本公司審計委員會委員擬自114年9月4日辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2025-07-10 18:15，「公告本公司審計委員會委員擬自114年9月4日辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2025-07-10-1814-271u5o","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2025-07-10","time":"18:14:55","subject":"公告本公司獨立董事擬自114年9月4日辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2025-07-10 18:14，「公告本公司獨立董事擬自114年9月4日辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-07-10-1734-25ngqv","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-07-10","time":"17:34:42","subject":"本公司新藥CBL-514注射劑用於減少腹部皮下脂肪之多國多中心樞紐三期臨床試驗申請，今日已完成加拿大HC送件","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-07-10 17:34，「本公司新藥CBL-514注射劑用於減少腹部皮下脂肪之多國多中心樞紐三期臨床試驗申請，今日已完成加拿大HC送件」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2025-07-10-1714-10k6rcg","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2025-07-10","time":"17:14:26","subject":"代子公司共信醫藥科技股份有限公司公告收到A基金公司對新設立美國子公司之投資意向書(LOI)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2025-07-10 17:14，「代子公司共信醫藥科技股份有限公司公告收到A基金公司對新設立美國子公司之投資意向書(LOI)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2025-07-10-1657-sbwr00","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2025-07-10","time":"16:57:19","subject":"公告本公司新任董事長事宜(更正)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2025-07-10 16:57，「公告本公司新任董事長事宜(更正)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2025-07-10-1656-ghmkig","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2025-07-10","time":"16:56:41","subject":"公告本公司薪酬委員辭職","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2025-07-10 16:56，「公告本公司薪酬委員辭職」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2025-07-10-1654-1thh46j","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2025-07-10","time":"16:54:36","subject":"公告本公司審計委員辭職","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2025-07-10 16:54，「公告本公司審計委員辭職」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2025-07-10-1653-1p3cw4y","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2025-07-10","time":"16:53:30","subject":"公告本公司獨立董事辭職","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2025-07-10 16:53，「公告本公司獨立董事辭職」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2025-07-10-1552-1tcbb62","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2025-07-10","time":"15:52:03","subject":"公告本公司114年6月份自結合併損益","clause":"第53款","fact_date":"2025-07-10","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2025-07-10 15:52，「公告本公司114年6月份自結合併損益」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2025-07-10-1546-i900nf","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-07-10","time":"15:46:30","subject":"公告本公司員工認股權憑證認股價格調整","clause":"第44款","fact_date":"2025-07-10","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2025-07-10 15:46，「公告本公司員工認股權憑證認股價格調整」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2025-07-10-1532-arkidq","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-07-10","time":"15:32:04","subject":"公告本公司114年第一次現金增資收足股款暨增資基準日","clause":"第44款","fact_date":"2025-07-10","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2025-07-10 15:32，「公告本公司114年第一次現金增資收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2025-07-10-1529-1tqa8nd","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2025-07-10","time":"15:29:34","subject":"華上生醫受邀參加華南永昌綜合證券舉辦之線上法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2025-07-10 15:29，「華上生醫受邀參加華南永昌綜合證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2025-07-10-1503-1bsdj8h","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2025-07-10","time":"15:03:40","subject":"公告本公司總經理辭職","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2025-07-10 15:03，「公告本公司總經理辭職」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2025-07-10-1440-lnj9s3","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2025-07-10","time":"14:40:19","subject":"公告本公司初次申請股票上市時所出具之承諾事項執行情形","clause":"第51款","fact_date":"2025-07-10","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2025-07-10 14:40，「公告本公司初次申請股票上市時所出具之承諾事項執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2025-07-10-1417-kin0xg","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2025-07-10","time":"14:17:57","subject":"公告本公司新任董事長事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2025-07-10 14:17，「公告本公司新任董事長事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4168-2025-07-10-1341-1fiirff","company_id":"4168","company":"醣聯","market":"上櫃","industry":"生技醫療","date":"2025-07-10","time":"13:41:53","subject":"公告本公司董事會決議辦理發行國內第四次有擔保轉換公司債","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醣聯（4168），2025-07-10 13:41，「公告本公司董事會決議辦理發行國內第四次有擔保轉換公司債」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4168-2025-07-10-1341-1uhskx3","company_id":"4168","company":"醣聯","market":"上櫃","industry":"生技醫療","date":"2025-07-10","time":"13:41:32","subject":"公告本公司董事會決議辦理現金增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醣聯（4168），2025-07-10 13:41，「公告本公司董事會決議辦理現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2025-07-10-1044-5rax5d","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2025-07-10","time":"10:44:06","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"第9款","fact_date":"2025-07-10","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2025-07-10 10:44，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2025-07-10-1037-oh1thc","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2025-07-10","time":"10:37:44","subject":"公告本公司法人董事代表人改派","clause":"第6款","fact_date":"2025-07-10","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2025-07-10 10:37，「公告本公司法人董事代表人改派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}